Efficient CRISPR/Cas9 gene ablation in uncultured naïve mouse T cells for in vivo studies

CRISPR/Cas9 technologies have revolutionised our understanding of gene function in complex biological settings, including T cell immunology. Current CRISPR-mediated gene deletion strategies in T cells require in vitro stimulation or culture that can both preclude studies of gene function within unmanipulated naïve T cells and can alter subsequent differentiation. Here we demonstrate highly efficient gene deletion within uncultured primary naïve murine CD8+ T cells by electroporation of recombinant Cas9/sgRNA ribonucleoprotein immediately prior to in vivo adoptive transfer. Using this approach, we generated single and double gene knock-out cells within multiple mouse infection models. Strikingly, gene deletion occurred even when the transferred cells were left in a naïve state, suggesting that gene deletion occurs independent of T cell activation. This protocol thus expands CRISPR-based probing of gene function beyond models of robust T cell activation, to encompass both naïve T cell homeostasis and models of weak activation, such as tolerance and tumour models.

[1]  John G Doench,et al.  A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system , 2019, Nature Communications.

[2]  Yu-Chen Hu,et al.  Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation , 2018, Nucleic acids research.

[3]  Akiko Seki,et al.  Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells , 2018, The Journal of experimental medicine.

[4]  R. Marone,et al.  Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells , 2018, The Journal of Immunology.

[5]  Jerilyn A Timlin,et al.  Delivering CRISPR: a review of the challenges and approaches , 2018, Drug delivery.

[6]  K. Rajewsky,et al.  Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line , 2016, Proceedings of the National Academy of Sciences.

[7]  Prashant Mali,et al.  A multifunctional AAV–CRISPR–Cas9 and its host response , 2016, Nature Methods.

[8]  Hao Ying,et al.  A Self-restricted CRISPR System to Reduce Off-target Effects. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  Namritha Ravinder,et al.  Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. , 2015, Journal of biotechnology.

[10]  Israel Steinfeld,et al.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.

[11]  Zhiping Weng,et al.  Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. , 2015, Human gene therapy.

[12]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[13]  Dominik Niopek,et al.  CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox. , 2014, Biotechnology journal.

[14]  Daesik Kim,et al.  Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins , 2014, Genome research.

[15]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[16]  Han-Hsuan Fu,et al.  A Potential New Pathway for PD-L1 Costimulation of the CD8-T Cell Response to Listeria monocytogenes Infection , 2013, PloS one.

[17]  E. Yang,et al.  Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation , 2013, Nature Immunology.

[18]  E. Kim,et al.  Immunotherapeutic effects of IL-7 during a chronic viral infection in mice. , 2011, Blood.

[19]  R. DePinho,et al.  IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology , 2011, Cell.

[20]  D. Koller,et al.  The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.

[21]  S. Way,et al.  PDL-1 Blockade Impedes T Cell Expansion and Protective Immunity Primed by Attenuated Listeria monocytogenes1 , 2008, The Journal of Immunology.

[22]  D. Roopenian,et al.  Minor histocompatibility antigens. , 1997, Current opinion in immunology.

[23]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[24]  H. Pircher,et al.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.